RNA interference-mediated inhibition of Hepatitis B virus replication

Chinese Science Bulletin

Volumn 49, Issue 14, 2004, Pages 1470-1475

  Tang, Ni ^a   Zhang, Bingqiang ^a   Yan, Ge ^a   Pu, Dan ^a   Gao, Xiaolin ^a   He, Tong Chuan ^b   Huang, Ailong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Antiviral therapy; Gene therapy; Hepatitis B virus; RNA interference; Viral replication

Indexed keywords

HEPATITIS B VIRUS; MAMMALIA;

EID: 33749654418     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1360/04wc0096     Document Type: Article

References (43)

1. Will, H., Reiser, W., Weimer, T. et al., Replication strategy of human hepatitis B virus, J. Virol., 1987, 61(3): 904-911.
2. Kao, J. H., Chen, D. S., Global control of hepatitis B virus infection, Lancet Infect. Dis., 2002, 2: 395-403.
3. Juszczyk, J., Clinical course and consequences of hepatitis B infection, Vaccine, 2000, 18(Suppl)1: 23-25.
4. Rabe, C., Cheng, B., Caselmann, W. H., Molecular mechanisms of hepatitis B virus-associated liver cancer, Dig. Dis., 2001, 19(4): 279-287.
5. Yao, N., Hong, Z., Lau, J. Y., Application of structural biology tools in the study of viral hepatitis and the design of antiviral therapy, Gastroenterology, 2002, 123(4): 1350-1363.
6. Niederau, C., Heintges, T., Lange, S. et al., Long-term follow-up of HBeAg-positive patients treated with interferon alpha for chronic hepatitis B, N. Engl. J. Med., 1996, 334(22): 1422-1427.
7. Mazzella, G., Saracco, G., Festi, D. et al., Long-term results with interferon therapy in chronic type B hepatitis: A prospective randomized trial, Am. J. Gastroenterol., 1999, 94(8): 2246-2250.
8. Zoulim, F., Therapy of chronic hepatitis B virus infection: Inhibition of the viral polymerase and other antiviral strategies, Antivir. Res., 1999, 44(1): 1-30.
9. Papatheodoridis, G. V., Dimou, E., Papadimitropoulos, V., Nucleoside analogues for chronic hepatitis B: Antiviral efficacy and viral resistance, Am. J. Gastroenterol., 2002, 97(7): 1618-1628.
10. Ayres, A., Bartholomeusz, A., Lau, G. et al., Lamivudine and Famciclovir resistant hepatitis B virus associated with fatal hepatic failure, J. Clin. Virol., 2003, 27(1): 111-116.
11. Lau, D. T., Everhart, J., Kleiner, D. E. et al., Long-term follow-up of patients with chronic hepatitis B treated with interferon alpha, Gastroenterology, 1997, 113(5): 1660-1667.
12. Hammond, S. M., Bernstein, E., Beach, D. et al., An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells, Nature, 2000, 404(6775): 293-296.
13. Sharp, P. A., RNA interference-2001, Genes Dev., 2001, 15(5): 485-490.
14. Fire, A., Xu, S., Montgomery, M. K. et al., Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, 1998, 391(6669): 806-811.
15. Chuang, C. F., Meyerowitz, E. M., Specific and heritable genetic interference by double-stranded RNA in Arabidopsis thaliana, Proc. Natl. Acad. Sci. USA, 2000, 97(9): 4985-4990.
16. Misquitta, L., Paterson, B. M., Targeted disruption of gene function in Drosophila by RNA interference (RNAi): a role for nautilus in embryonic somatic muscle formation, Proc. Natl. Acad. Sci. USA, 1999, 96(4): 1451-1456.
17. Matzke, M., Matzke, A., Kooter, J. M., RNA: Guiding gene silencing. Science, 2001, 293(5532): 1080-1083.
18. Ma Jun, Zhou Honglin, Su Lei et al., Effects of exogenous double-stranded RNA on the basonuclin gene expression in mouse oocytes, Science in China, Ser. C, 2002, 45(6): 593-603.
19. Elbashir, S. M., Harborth, J., Lendeckel, W., Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells, Nature, 2001, 411(6836): 494-498.
20. Sui, G., Soohoo, C., Affar, E. B. et al., A DNA vector-based RNAi technology to suppress gene expression in mammalian cells, Proc. Nat. Acad. Sci. USA, 2002, 99(8): 5515-5520.
21. Jacque, J. M., Triques, K., Stevenson, M., Modulation of HIV-1 replication by RNA interference, Nature, 2002, 418(6896): 435-438.
22. Coburn, G. A., Cullen, B. R., Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference, J. Virol., 2002, 76(18): 9225-9231.
23. Gitlin, L., Karelsky, S., Andino, R., Short interfering RNA confers intracellular antiviral immunity in human cells, Nature, 2002, 418(6896): 430-434.
24. Novina, C. D., Murrray, M. F., Dykxhoorn, D. M. et al., siRNA-directed inhibition of HIV-1 infection, Nat. Med., 2002, 8(7): 681-686.
25. Paul, C. P., Good, P. D., Winer, I. et al., Effective expression of small interfering RNA in human cells, Nat. Biotechnol., 2002, 20(5): 505-508.
26. Sprinzl, M. F., Oberwinkler, H., Schaller, H. et al., Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: Crossing the species barrier, J. Virol., 2001, 75(11): 5108-5118.
27. Tang Ni, Huang Ailong, Zhang Bingqiang et al., Construction of recombinant eukaryotic expression plasmid containing 1,3-fold-overlength genome of HBV, Zhonghua Gan Zang Bing Za Zhi (in Chinese), 2003, 11(8): 464-466.
28. Hamasaki, K., Nakao, K., Matsumoto, K. et al., Short interfering RNA-directed inhibition of hepatitis B virus replication, FEBS Letters, 2003, 543(1-3): 51-54.
29. Shlomai, A., Shaul, Y., Inhibition of hepatitis B virus expression and replication by RNA interference, Hepatology, 2003, 37(4): 764-770.
30. Scherr, M., Morgan, M. A., Eder, M., Gene silencing mediated by small interfering RNAs in mammalian cells, Curr. Med. Chem., 2003, 10(3): 245-256.
31. Fjose, A., Ellingsen, S., Wargelius, A. et al., RNA interference: Mechanisms and applications, Biotechnol. Annu. Rev., 2001, 7: 31-57.
32. Carthew, R. W., Gene silencing by double-stranded RNA, Curr. Opin. Cell. Biol., 2001, 13(2): 244-248.
33. Nassal, M., Schaller, H., Hepatitis B virus replication - an update, J. Virol. Hepat., 1996, 3(5): 217-226.
34. Moolla, N., Kew, M., Arbuthnot, P., Regulatory elements of hepatitis B virus transcription, J. Viral Hepat., 2002, 9(5): 323-331.
35. Birnbaum, F., Nassal, M., Hepatitis B virus nucleocapsid assembly: Primary structure requirements in the core protein, J. Virol., 1990, 64(7): 3319-3330.
36. McCAffrey, A. P., Nakai, H., Pandey, K. et al., Inhibition of hepatitis B virus in mice by RNA interference, Nat. Biotechnol., 2003, 21(6): 639-644.
37. Lee, N. S., Dohjima, T., Bauer, G. et al., Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells, Nat. Biotechnol., 2002, 20(5): 500-505.
38. Randall, G., Grakoui, A., Rice, C. M., Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs, Proc. Natl. Acad. Sci. USA, 2003, 100(1): 235-240.
39. Yokota, T., Sakamoto, N., Enomoto, N. et al., Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs, EMBO Rep., 2003, 4(6): 602-608.
40. Ying, C., De, Clercq, E., Neyts, J., Selective inhibition of hepatitis B virus replication by RNA interference, Biochem. Biophys. Res. Commun., 2003, 309(2): 482-484.
41. Klein, C., Bock, C. T., Wedemeyer, H. et al., Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA, Gastroenterology, 2003, 125(1): 9-18.
42. Wilson, J. A., Jayasena, S., Khvorova, A. et al., RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells, Proc. Natl. Acad. Sci. USA, 2003, 100(5): 2783-2788.
43. Kapadia, S. B., Brideua-Andersen, A., Chisari, F. V., Interference of hepatitis C virus RNA replication by short interfering RNAs, Proc. Natl. Acad. Sci. USA, 2003, 100(4): 2014-2018.